Literature DB >> 29773655

FOXP3 interacts with hnRNPF to modulate pre-mRNA alternative splicing.

Jianguang Du1, Qun Wang1, Steven F Ziegler2, Baohua Zhou3,4.   

Abstract

FOXP3 promotes the development and function of regulatory T cells mainly through regulating the transcription of target genes. RNA alternative splicing has been implicated in a wide range of physiological and pathophysiological processes. We report here that FOXP3 associates with heterogeneous nuclear ribonucleoprotein (hnRNP) F through the exon 2-encoded region of FOXP3 and the second quasi-RNA recognition motif (qRRM) of hnRNPF. FOXP3 represses the ability of hnRNPF to bind to its target pre-mRNA and thus modulates RNA alternative splicing. Furthermore, overexpression of mouse hnRNPF in in vitro-differentiated regulatory T cells (Tregs) reduced their suppressive function. Thus, our studies identify a novel mechanism by which FOXP3 regulates mRNA alternative splicing to modulate the function of regulatory T cells.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  RNA splicing; RNA-protein interaction; Treg; alternative splicing; forkhead box P3 (FOXP3); heterogeneous nuclear ribonucleoprotein (hnRNP); immunology; immunosuppression

Mesh:

Substances:

Year:  2018        PMID: 29773655      PMCID: PMC6028976          DOI: 10.1074/jbc.RA117.001349

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Structural basis of G-tract recognition and encaging by hnRNP F quasi-RRMs.

Authors:  Cyril Dominguez; Jean-François Fisette; Benoit Chabot; Frédéric H-T Allain
Journal:  Nat Struct Mol Biol       Date:  2010-06-06       Impact factor: 15.369

2.  Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.

Authors:  Masahiro Ono; Hiroko Yaguchi; Naganari Ohkura; Issay Kitabayashi; Yuko Nagamura; Takashi Nomura; Yoshiki Miyachi; Toshihiko Tsukada; Shimon Sakaguchi
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

3.  Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells.

Authors:  Hozefa S Bandukwala; Yongqing Wu; Markus Feuerer; Yongheng Chen; Bianca Barboza; Srimoyee Ghosh; James C Stroud; Christophe Benoist; Diane Mathis; Anjana Rao; Lin Chen
Journal:  Immunity       Date:  2011-03-31       Impact factor: 31.745

4.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

5.  Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3.

Authors:  Jianguang Du; Chunjian Huang; Baohua Zhou; Steven F Ziegler
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 6.  FOXP3 and scurfy: how it all began.

Authors:  Fred Ramsdell; Steven F Ziegler
Journal:  Nat Rev Immunol       Date:  2014-04-11       Impact factor: 53.106

Review 7.  Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn.

Authors:  Nicole M Martinez; Kristen W Lynch
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

8.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Transcription factor Foxp3 and its protein partners form a complex regulatory network.

Authors:  Dipayan Rudra; Paul deRoos; Ashutosh Chaudhry; Rachel E Niec; Aaron Arvey; Robert M Samstein; Christina Leslie; Scott A Shaffer; David R Goodlett; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

View more
  6 in total

Review 1.  The emerging role of transcription factor FOXP3 in thyroid cancer.

Authors:  Zhongqin Gong; Hao Jia; Lingbin Xue; Dongcai Li; Xianhai Zeng; Minghui Wei; Zhimin Liu; Michael C F Tong; George G Chen
Journal:  Rev Endocr Metab Disord       Date:  2021-08-31       Impact factor: 6.514

2.  The Drosophila hnRNP F/H homolog Glorund recruits dFMRP to inhibit nanos translation elongation.

Authors:  Yingshi Peng; Elizabeth R Gavis
Journal:  Nucleic Acids Res       Date:  2022-06-14       Impact factor: 19.160

3.  CD4+ T Cell-Specific Proteomic Pathways Identified in Progression of Hypertension Across Postmenopausal Transition.

Authors:  Joshua A Uhlorn; Nathaniel A Husband; Melissa J Romero-Aleshire; Caitlin Moffett; Merry L Lindsey; Paul R Langlais; Heddwen L Brooks
Journal:  J Am Heart Assoc       Date:  2021-01-07       Impact factor: 5.501

4.  PIF4 and HOOKLESS1 Impinge on Common Transcriptome and Isoform Regulation in Thermomorphogenesis.

Authors:  Huanhuan Jin; Jingya Lin; Ziqiang Zhu
Journal:  Plant Commun       Date:  2020-02-19

Review 5.  Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation.

Authors:  Zhihui Dou; Dapeng Zhao; Xiaohua Chen; Caipeng Xu; Xiaodong Jin; Xuetian Zhang; Yupei Wang; Xiaodong Xie; Qiang Li; Cuixia Di; Hong Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-06-12

6.  C9-ALS/FTD-linked proline-arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation.

Authors:  Hiroaki Suzuki; Yoshio Shibagaki; Seisuke Hattori; Masaaki Matsuoka
Journal:  Cell Death Dis       Date:  2019-10-03       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.